Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |